Sharon J Krinsky-McHale, Cynthia M Kovacs, Joseph H Lee, Tracy A Listwan, Deborah I Pang, Nicole Schupf, Benjamin Tycko, Warren B Zigman, Wayne Silverman
{"title":"Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.","authors":"Sharon J Krinsky-McHale, Cynthia M Kovacs, Joseph H Lee, Tracy A Listwan, Deborah I Pang, Nicole Schupf, Benjamin Tycko, Warren B Zigman, Wayne Silverman","doi":"10.1002/dad2.70076","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>New Alzheimer's disease (AD) treatments have created an urgent need for accurate early diagnosis of high-risk adults with Down syndrome (DS), distinguishing prodromal DS-AD symptoms from lifelong cognitive impairments. Often, clinicians will need to evaluate dementia status during a single assessment, and here we describe empirically supported methods effective under such circumstances.</p><p><strong>Methods: </strong>Archived data collected between 1987 and 2017 included longitudinal findings for 144 individuals maintaining cognitive stability and 126 developing prodromal DS-AD. Response operating characteristic analyses compared groups, defined by the presence/absence of prodromal DS-AD, for a single assessment.</p><p><strong>Results: </strong>Groups differed on all measures without adjusting for developmental history, 0.717 < areas under the curve < 0.859, <i>P</i>s < 0.0001. The balance between sensitivity and specificity improved slightly when developmental histories were considered.</p><p><strong>Discussion: </strong>The present study demonstrated that one-time assessments can inform clinical judgments when diagnosing adults at risk for DS-AD. Knowledge of developmental history is valuable but non-essential.</p><p><strong>Highlights: </strong>Non-overlapping distributions were observed for preclinical and prodromal Alzheimer's disease (AD) groups.Receiver operating characteristic area under the curve analyses were in the acceptable to excellent range for all measures.Performance was sensitive to both the severity of intellectual disability and the stage of Down syndrome-AD progression.Episodic memory tests were sensitive to the transition from preclinical to prodromal AD.Performance results at a single time point can inform dementia status decisions.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 1","pages":"e70076"},"PeriodicalIF":4.0000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812125/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: New Alzheimer's disease (AD) treatments have created an urgent need for accurate early diagnosis of high-risk adults with Down syndrome (DS), distinguishing prodromal DS-AD symptoms from lifelong cognitive impairments. Often, clinicians will need to evaluate dementia status during a single assessment, and here we describe empirically supported methods effective under such circumstances.
Methods: Archived data collected between 1987 and 2017 included longitudinal findings for 144 individuals maintaining cognitive stability and 126 developing prodromal DS-AD. Response operating characteristic analyses compared groups, defined by the presence/absence of prodromal DS-AD, for a single assessment.
Results: Groups differed on all measures without adjusting for developmental history, 0.717 < areas under the curve < 0.859, Ps < 0.0001. The balance between sensitivity and specificity improved slightly when developmental histories were considered.
Discussion: The present study demonstrated that one-time assessments can inform clinical judgments when diagnosing adults at risk for DS-AD. Knowledge of developmental history is valuable but non-essential.
Highlights: Non-overlapping distributions were observed for preclinical and prodromal Alzheimer's disease (AD) groups.Receiver operating characteristic area under the curve analyses were in the acceptable to excellent range for all measures.Performance was sensitive to both the severity of intellectual disability and the stage of Down syndrome-AD progression.Episodic memory tests were sensitive to the transition from preclinical to prodromal AD.Performance results at a single time point can inform dementia status decisions.
期刊介绍:
Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.